Innovative method to deliver THC: Transmucosal patch increases drug's absorption

Three UM Scientists Develop Innovative Method to Deliver THC
Michael A. Repka displays a transmucosal patch, placed just above the gumline (top center) of this set of false teeth. Credit: Robert Jordan

(Medical Xpress)—An innovative delivery method for tetrahydrocannabinol, the main psychoactive constituent of Cannabis, is being developed at the University of Mississippi.

School of Pharmacy faculty members Michael A. Repka, Soumyajit Majumdar and Mahmoud A. ElSohly have developed a transmucosal THC patch to overcome problems related to taking the drug in pill form. The patch is administered above the gum line.

"The main issue with oral THC delivery is that the drug gets metabolized before it reaches the bloodstream, resulting in a lot of variability in the dosage patients receive," said Repka, chair of pharmaceutics and director of the Pii Center for Pharmaceutical Technology. "That has been a longtime problem. Delivering through the oral mucosa gives better absorption with minimal variability. When it goes into the mucosa, it bypasses , allowing for a lower dosage of the drug than when delivered orally."

The project began nearly seven years ago and stemmed from ElSohly's previous research on a THC suppository. The concept was to develop amino acid prodrugs, or drug precursors, to make THC more hydrophilic, or water-soluble, which aids in absorption.

"We began with the same compounds that were used in the suppository," said ElSohly, president of ElSohly Laboratories Inc., as well as professor of pharmaceutics and research professor in UM's National Center for Natural Products Research. "However, we found that the absorption took too long in the transmucosa, so we modified the chemistry and made another set of compounds that have better bioavailability, better stability and a longer shelf life."

The formulas were first screened in rabbits, then in pigs at the UM Medical Center. Two of the prodrugs stood out as candidates for further testing.

"Our findings indicate that the buccal film-prodrug combination produces significantly higher plasma ," said Majumdar, associate professor of pharmaceutics and associate director of the Pii Center.

"It looks like we have a successful product with good bioavailability and blood levels," ElSohly said. "We have observed absorption for up to 10 hours."

The patch is processed using hot-melt extrusion, a process that is used widely in the plastics industry and is coming into its own in pharmaceutical manufacturing because it produces products of uniform shape and density. Fast-dissolving films or tablets are often produced using this technology.

"There are a lot of advantages to using the hot-melt extrusion technology," Repka said. "It's a simple process in which the drug can be extruded into a film and die cut into desired sizes. It's an innovative way to produce these patches."

"This Institutional Development Award Center of Biomedical Research Excellence grant has enabled the University of Mississippi to successfully train and mentor developing investigators, build state-of-the-art research infrastructure and conduct exemplary research activities," said Fred Taylor, an IDeA program official at NIH's NIGMS. "In pursuing these goals of the IDeA program, the center is making an impact on biomedical research and health in Mississippi, the region and the nation."

Continued investigation of the two prodrug candidates is expected to lead to testing in humans.

"I'm expecting even better results in humans," Repka said. "We are looking into partnership opportunities that could give us the opportunity to begin these tests. I'm confident that the combination of hot-melt extrusion technology and the oral transmucosal route is a novelty in which many will be interested."

add to favorites email to friend print save as pdf

Related Stories

Pill using ultrasound may replace daily needles

Jun 26, 2012

(Medical Xpress) -- For patients who need daily injections to stay on course, being able instead to take their medication orally would help improve patients’ quality of life and perhaps even outcomes. ...

Novel chewing gum formulation helps prevent motion sickness

Oct 17, 2012

A new prototype for medicated chewing gum has been developed for motion sickness that may offer many advantages over conventional oral solid dosage forms. About 33 percent of people are susceptible to motion sickness in mild ...

Microneedles enhance drug administration through skin

Feb 04, 2008

In what is believed to be the first peer-reviewed study of its kind involving human subjects, researchers at the University of Kentucky College of Pharmacy and the Georgia Institute of Technology have demonstrated ...

Recommended for you

Express Scripts turns to AbbVie in huge hepatitis C deal

3 hours ago

The nation's largest pharmacy benefits manager is throwing its weight into a fight over the high cost of treating hepatitis C, saying it will cover a drug from AbbVie while pulling back on those from rival drugmakers.

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.